Balyasny Asset Management LLC Enochian Biosciences Inc Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	N/A	13,571 Added 52.7%	39,324 $180,000
Q4 2023 Feb 14, 2024	BUY	$4.3 - $4.7 $110,737 - $121,039	25,753 New	25,753 $118,000
Q1 2022 May 16, 2022	SELL	$4.42 - $9.0 $62,405 - $127,071	-14,119 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $94,738 - $177,193	14,119 New	14,119 $103,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.